AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 100 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $891,224 | +274.7% | 21,817 | +134.1% | 0.00% | – |
| Q1 2024 | $237,846 | -26.6% | 9,320 | -53.0% | 0.00% | – |
| Q3 2022 | $324,000 | +14.5% | 19,842 | +1.9% | 0.00% | – |
| Q2 2022 | $283,000 | +3.7% | 19,480 | +2.0% | 0.00% | – |
| Q1 2022 | $273,000 | -40.7% | 19,093 | -1.4% | 0.00% | – |
| Q4 2021 | $460,000 | -17.0% | 19,360 | -14.0% | 0.00% | -100.0% |
| Q3 2021 | $554,000 | -97.9% | 22,513 | -97.9% | 0.00% | -96.0% |
| Q2 2021 | $26,126,000 | +17.2% | 1,057,312 | +3.4% | 0.02% | +8.7% |
| Q1 2021 | $22,291,000 | +2.4% | 1,022,056 | +19.8% | 0.02% | -4.2% |
| Q4 2020 | $21,776,000 | -3.7% | 853,292 | +6.2% | 0.02% | -17.2% |
| Q3 2020 | $22,615,000 | -10.2% | 803,367 | -9.8% | 0.03% | -14.7% |
| Q2 2020 | $25,173,000 | – | 890,780 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |